GPhA, PhRMA To Tout Generic Labeling Alternative They Floated To FDA

The generic and brand pharmaceutical lobby groups will walk into an FDA public meeting next month ready to tout an alternative generic drug labeling proposal they jointly crafted and quietly sent to the agency in mid-November, sources say. Their alternative to FDA's highly contentious proposed labeling rule, which has pit industry against consumer advocates for months, calls for the agency to take the reins and require that brand and generic drug companies simultaneously update their labels under a four-step process...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.